BioLineRx Ltd.
A clinical-stage biopharmaceutical company developing therapies for oncology and rare diseases.
BLRX | TA
Overview
Corporate Details
- ISIN(s):
- US09071M2052 (+1 more)
- LEI:
- 529900AKIOSC15Y63R18
- Country:
- Israel
- Address:
- Modi'in Technology Park, 2 HaMa'ayan Street, 7177871 Modi'in
- Website:
- https://www.biolinerx.com/
- Sector:
- Manufacturing
Description
BioLineRx Ltd. is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for oncology and rare diseases. The company leverages its drug development capabilities to advance novel, early-stage therapeutic candidates through the clinical development process toward regulatory approval. Its pipeline consists of treatments, including small molecules, designed to address unmet medical needs and deliver meaningful benefits to patients. BioLineRx also partners with other drug developers to advance their early-stage programs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-05-28 16:05 |
Reports First Quarter 2024 Financial Results and Recent Corporate
and Portfolio…
|
English | 36.6 KB | ||
| 2024-05-24 16:25 |
Abstract on Pilot Study Data from Phase 2 Combination Clinical Trial Evaluating…
|
English | 532.7 KB | ||
| 2024-05-24 16:25 |
Abstract on Pilot Study Data from Phase 2 Combination Clinical Trial Evaluating…
|
English | 36.5 KB | ||
| 2024-05-19 11:55 |
BioLineRx Announces Receipt of Nasdaq Minimum Bid Price Notification
|
English | 521.9 KB | ||
| 2024-05-19 11:55 |
BioLineRx Announces Receipt of Nasdaq Minimum Bid Price Notification
|
English | 36.3 KB | ||
| 2024-05-06 16:05 |
BioLineRx Announces Poster Presentation on Economic Model Data for APHEXDA® (mo…
|
English | 539.4 KB | ||
| 2024-05-06 16:05 |
BioLineRx Announces Poster Presentation on Economic Model Data for APHEXDA® (mo…
|
English | 36.6 KB | ||
| 2024-04-17 16:32 |
BioLineRx Announces Poster Presentation on Apheresis Center Efficiency and CXCR…
|
English | 545.7 KB | ||
| 2024-04-17 16:32 |
BioLineRx Announces Poster Presentation on Apheresis Center Efficiency and CXCR…
|
English | 36.5 KB | ||
| 2024-04-10 16:32 |
BioLineRx Accesses Second Tranche of $20 Million Under Previously Announced $40…
|
English | 525.2 KB | ||
| 2024-04-10 16:32 |
BioLineRx Accesses Second Tranche of $20 Million Under Previously Announced $40…
|
English | 36.4 KB | ||
| 2024-04-01 19:43 |
Definitive agreement with certain institutional investors providing for the iss…
|
English | 1.1 MB | ||
| 2024-04-01 19:43 |
Definitive agreement with certain institutional investors providing for the iss…
|
English | 36.2 KB | ||
| 2024-04-01 19:40 |
PROSPECTUS SUPPLEMENT - 7,500,000 ADS and Warrants to Purchase 7,500,000 ADS
|
English | 275.2 KB | ||
| 2024-04-01 19:40 |
PROSPECTUS SUPPLEMENT - 7,500,000 ADS and Warrants to Purchase 7,500,000 ADS
|
English | 36.2 KB |
Automate Your Workflow. Get a real-time feed of all BioLineRx Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BioLineRx Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BioLineRx Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
